Buscador de publicacions

Publicacions

  • Fernández-Cooke E, Barrios Tascón A, Antón-López J, Grasa Lozano CD, Sánchez-Manubens J and Calvo-Benet C.

    Infecciones previas o coincidentes con la sospecha de enfermedad de Kawasaki ¿debemos cambiar nuestra actitud?

    ANALES DE PEDIATRIA . 90(4): 213-218. Nº de cites: 5

    [doi:10.1016/j.anpedi.2018.06.017]

  • Sánchez-Manubens J, Iglesias-Jimenez E and Anton-Lopez J.

    Canakinumab for the treatment of hyperimmunoglobulin D syndrome

    EXPERT REVIEW OF CLINICAL IMMUNOLOGY . 15(3): 215-220. Nº de cites: 7

    [doi:10.1080/1744666X.2019.1571410]

  • Sánchez-Manubens J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E, Calzada-Hernández J, Rodó X and Morguí JA.

    Kawasaki disease is more prevalent in rural areas of Catalonia (Spain)

    ANALES DE PEDIATRIA . 87(4): 226-231. Nº de cites: 4

    [doi:10.1016/j.anpedi.2016.12.009]

  • Sánchez-Manubens J, Gelman A, Franch N, Teodoro S, Palacios JR, Rudi N, Rivera J and Anton-Lopez J.

    A child with resistant Kawasaki disease successfully treated with anakinra: a case report

    BMC PEDIATRICS . 17: 102-102. Nº de cites: 32

    [doi:10.1186/s12887-017-0852-6]

  • Sánchez-Manubens J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E, Calzada-Hernández J, Borlan S, Gimenez-Roca C and Rivera J.

    Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population

    RHEUMATOLOGY INTERNATIONAL . 36(7): 905-910. Nº de cites: 29

    [doi:10.1007/s00296-016-3499-y]

  • Sánchez-Manubens J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E and Calzada-Hernández J.

    Incidence, epidemiology and clinical features of Kawasaki disease in Catalonia, Spain

    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . 34(3): 139-144. Nº de cites: 15

  • Calzada-Hernández J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E, Ricart S, Martín-de-Carpi J, García de Vicuña-Muñoz C, Torrente V, Sánchez-Manubens J, Giménez-Roca CI, Rozas L, Juncosa-Morros T, Fortuny-Guasch C and Noguera-Julián A.

    Tuberculosis in pediatric patients treated with anti-TNFa drugs: a cohort study

    PEDIATRIC RHEUMATOLOGY . 13: 54-54. Nº de cites: 34

    [doi:10.1186/s12969-015-0054-4]

  • Giménez-Roca CI, Iglesias-Jimenez E, Torrente-Segarra V, Bou-Torrent R, Sánchez-Manubens J, Calzada-Hernández J, Samuel Hernandez Baldizon, Ricart S and Anton-Lopez J.

    Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age

    RHEUMATOLOGY INTERNATIONAL . 35(2): 323-326. Nº de cites: 12

    [doi:10.1007/s00296-014-3103-2]

  • Iglesias-Jimenez E, Torrente V, Bou-Torrent R, Ricart S, Maria Isabel Gonzalez Fernandez, Sánchez-Manubens J, Calzada-Hernández J and Anton-Lopez J.

    Non-systemic juvenile idiopathic arthritis outcome after reaching clinical remission with anti-TNF-alpha therapy: a clinical practice observational study of patients who discontinued treatment

    RHEUMATOLOGY INTERNATIONAL . 34(8): 1053-1057. Nº de cites: 22

    [doi:10.1007/s00296-013-2884-z]

  • Sánchez-Manubens J, Bou-Torrent R and Anton-Lopez J.

    Diagnosis and classification of Kawasaki disease

    JOURNAL OF AUTOIMMUNITY . 48-49: 113-117. Nº de cites: 48

    [doi:10.1016/j.jaut.2014.01.010]